Brain abnormalities detected on magnetic resonance imaging of amphetamine users presenting to an emergency department: A pilot study

Medical Journal of Australia

Volumn 193, Issue 5, 2010, Pages 266-268

  Fatovich, Daniel M ^a   McCoubrie, David L ^b   Song, Swithin J ^b   Rosen, David M ^b   Lawn, Nick D ^b   Daly, Frank F ^b  

^a Harry Perkins Institute of Medical Research   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; CANNABIS; COCAINE; DIAMORPHINE; LYSERGIDE; METHAMPHETAMINE;

ADULT; AGITATION; ANXIETY DISORDER; ARTICLE; BRAIN DISEASE; BRAIN EDEMA; CIGARETTE SMOKING; CLINICAL ARTICLE; CONSCIOUSNESS DISORDER; DEMOGRAPHY; DRINKING BEHAVIOR; DRUG FEVER; DRUG USE; EMERGENCY WARD; FEMALE; FEVER; HEADACHE; HEART PALPITATION; HUMAN; INSOMNIA; MALE; MEMORY DISORDER; MIGRAINE; MINI MENTAL STATE EXAMINATION; MOOD DISORDER; MUSHROOM; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; PSYCHOSIS; PYELONEPHRITIS; SCLEROSIS; SEIZURE; SIDE EFFECT; SUICIDAL BEHAVIOR; TERTIARY HEALTH CARE; AUSTRALIA; BRAIN DISEASES; COMPLICATION; DRUG ABUSE; EMERGENCY HEALTH SERVICE; PATHOLOGY; PREVALENCE; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; AMPHETAMINE-RELATED DISORDERS; BRAIN DISEASES; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PILOT PROJECTS; PREVALENCE; WESTERN AUSTRALIA; YOUNG ADULT;

EID: 77957668287     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2010.tb03904.x     Document Type: Article

References (13)

1. Gunter TD. Control of methamphetamine misuse. BMJ 2007; 334: 1176-1177.
2. United Nations Office on Drugs and Crime. World Drug Report 2009. New York, 2009. http://www.unodc.org/unodc/en/data-andanalysis/WDR-2009.html (accessed Jul 2010).
3. Australian Institute of Health and Welfare. 2007 National Drug Strategy Household Survey. Canberra , AIHW: 2008. http://www.aihw.gov.au/publications/ index.cfm/title/10579 (accessed Jul 2010).
4. Meredith CW, Jaffe C, Ang-Lee K, Saxon AJ. Implications of chronic methamphetamine use: a literature review. Harv Rev Psychiatry 2005; 13: 141-154.
5. Berman S, O'Neill J, Fears S, et al. Abuse of amphetamines and structural abnormalities in the brain. Ann N Y Acad Sci 2008; 1141: 195-220.
6. Chang L, Alicata D, Ernst T, Volkow N. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 2007; 102: 16-32.
7. Ernst T, Chang L, Leonido-Yee M, Speck O. Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study. Neurology 2000; 54: 1344-1349.
8. Thompson PM, Hayashi KM, Simon SL, et al. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 2004; 24: 6028-6036.
9. Gray SD, Fatovich DM, McCoubrie DL, Daly FF. Amphetamine-related presentations to an inner-city tertiary emergency department: a prospective evaluation. Med J Aust 2007; 186: 336-339.
10. Dick JP, Guiloff RJ, Stewart A, et al. Mini-mental state examination in neurological patients. J Neurol Neurosurg Psychiatry 1984; 47: 496-499.
11. Gardner H, Lawn N, Fatovich DM, Archer JS. Acute hippocampal sclerosis following ecstasy ingestion. Neurology 2009; 73: 567-569.
12. Katzman GL, Dagher AP, Patronas NJ. Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers. JAMA 1999; 282: 36-39.
13. Bae SC, Lyoo IK, Sung YH, et al. Increased white matter hyperintensities in male methamphetamine abusers. Drug Alcohol Depend 2006; 81: 83-88.